Stock CSPCY CSPC PHARMACEUTICAL GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News CSPC Pharmaceutical Group Limited OTC Markets

Equities

CSPCY

US12591J2078

Delayed OTC Markets
Other stock markets
 14:33:59 01/07/2024 BST 		5-day change 1st Jan Change
3.16 USD +1.61% Intraday chart for CSPC Pharmaceutical Group Limited -1.19% -14.36%
06-28 CSPC Pharmaceutical Group Limited Announces Enlonstobart Injection Obtains Conditional Marketing Approval CI
06-28 CSPC Pharma's Breast Cancer Drug Gets Approval in China MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
CSPC Pharmaceutical Group Limited Announces Enlonstobart Injection Obtains Conditional Marketing Approval
CI
CSPC Pharma's Breast Cancer Drug Gets Approval in China
MT
CSPC Pharmaceutical Group Limited Announces Palbociclib Tablets Obtains Drug Registration Approval
CI
Global markets live: Bayer, FedEx, Nvidia, KKR, Verizon...
Our Logo
China approves CSPC Pharma mRNA cancer therapy for clinical trials
RE
CSPC Pharmaceutical Gets Go-Ahead for Clinical Trial of Multiple Myeloma Drug in China
MT
CSPC Pharmaceutical Group Limited Obtains Approval from National Medical Products Administration of the People's Republic of China to Conduct Clinical Trials in China
CI
CSPC Pharmaceutical Group Limited commences an Equity Buyback for 1,189,609,173 shares, representing 10% of its issued share capital, under the authorization approved on May 28, 2024.
CI
CSPC Pharmaceutical Buys Back Further Shares
MT
CSPC Pharmaceutical Repurchases 7 Million Shares
MT
CSPC Pharmaceutical Trustee Repurchases Further Shares Under Award Scheme
MT
Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic
RE
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
RE
Corbus Pharmaceuticals Reaches 2-Year High After Drug Results
DJ
CSPC Pharmaceutical’s Trustee Buys Back Further Shares
MT
CSPC Pharmaceutical Group Limited Receives Approval for Olaparib Tablets by the National Medical Products Administration of the People's Republic of China
CI
Final dividend
FA
CSPC Pharmaceutical Repurchases 3 Million Shares
MT
CSPC Pharmaceutical Group Limited Announces Board Changes
CI
CSPC Pharmaceutical Group Limited Approves Final Dividend for the Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1093 Stock
  4. CSPCY Stock
  5. News CSPC Pharmaceutical Group Limited